🇺🇸 FDA
Pipeline program

FX005

FX005-2010-001

Phase 2 small_molecule completed

Quick answer

FX005 for Osteoarthritis, Knee is a Phase 2 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Osteoarthritis, Knee
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials